T1	Participants 63 89	chronic alcoholic patients
T2	Participants 194 322	32 randomly selected hospitalized male alcoholic patients with clinical, biochemical and histological evidence of hepatic damage
T3	Participants 1222 1265	patients with alcoholic liver disease (ALD)
